Durham-based Tavros Therapeutics, a precision oncology company spun out of Duke University, has been acquired by a subsidiary of global life sciences titan Bayer AG. Financial terms of the deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback